Jose‑Carlos Gutiérrez‑Ramos, Ph.D., serves as a venture partner at Flagship Pioneering. Previously, he was CEO and president of Synlogic, where he led the company from early discovery to the clinical stage and to the public market. Prior to leading Synlogic, Jose‑Carlos was group senior vice president of worldwide research and development and global head of biotherapeutics research and development at Pfizer from 2009 to 2015 and at GSK from 2006-2009. During his pharmaceutical tenure, Jose-Carlos’ teams have developed and brought two drugs to market, five to phase III, and multiple to phase I and II.
Jose‑Carlos trained as an immunologist in Spain, Germany, and Switzerland. He started his academic career as assistant professor of genetics at Harvard Medical School. He has authored more than 150 peer-reviewed publications.